Clinical trials recruiting for Lung Cancer, Non-small Cell

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC
  NCT06769295 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Phase II Study of SKB571 in Patients With Lung Cancer
  NCT07230405 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
  NCT06228326 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
  NCT07166003 · Phase: Not specified · Ages: 18 Years to 79 Years · Sex: All (male and female) · 1 location
• Engagement of Veterans With Lung Cancer
  NCT07219251 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)
  NCT06405230 · Phase: Phase 1, Phase 2 · Ages: 30 Years and older · Sex: All (male and female) · 1 location
• Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
  NCT05598528 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device
  NCT07561567 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  NCT07198841 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 7 locations
• Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
  NCT07405190 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer
  NCT06889467 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
  NCT07500376 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)
  NCT06926790 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
  NCT06963307 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
  NCT06659042 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
  NCT07145255 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
  NCT06648317 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• SL-28 for Advanced Solid Tumours
  NCT07341737 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques
  NCT06687408 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients
  NCT06786468 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
  NCT06538012 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 90 Years · Sex: All (male and female) · 1 location
• TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
  NCT05628376 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
  NCT07216209 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
  NCT06659458 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: Female · 1 location

Related conditions

Trials recruiting for Lung Cancer, Non-small Cell often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Lung Cancer, Non-small Cell trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.